Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 75, Issue Supplement_4, Pages S562-S570
Publisher
Oxford University Press (OUP)
Online
2022-09-10
DOI
10.1093/cid/ciac754
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Virologic non‐suppression and early loss to follow up among pregnant and non‐pregnant adolescents aged 15–19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study
- (2022) Patience Nyakato et al. Journal of the International AIDS Society
- Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
- (2022) Sinead Delany-Moretlwe et al. LANCET
- Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial
- (2022) Theodore D Ruel et al. Lancet HIV
- Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants
- (2021) Elizabeth J McFarland et al. JOURNAL OF INFECTIOUS DISEASES
- Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
- (2021) Raphael J. Landovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review of paediatric gastrointestinal physiology relevant to the absorption of orally administered medicines
- (2021) Erik Wollmer et al. ADVANCED DRUG DELIVERY REVIEWS
- Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children
- (2021) Anna Turkova et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients
- (2020) Zaid H. Temrikar et al. PEDIATRIC DRUGS
- Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach
- (2020) Jerry Li et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Adolescent participation in HIV research: consortium experience in low and middle-income countries and scoping review
- (2020) Suzanne Day et al. Lancet HIV
- Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants
- (2019) Coleen K Cunningham et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
- (2019) Martin R Gaudinski et al. Lancet HIV
- Optimal Antiretroviral Prophylaxis in Infants at High Risk of Acquiring HIV
- (2018) Sara Beste et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Factors impacting antiretroviral therapy adherence among human immunodeficiency virus–positive adolescents in Sub-Saharan Africa: a systematic review
- (2018) N. Ammon et al. PUBLIC HEALTH
- Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults
- (2018) Martin R. Gaudinski et al. PLOS MEDICINE
- Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action
- (2018) Martina Penazzato et al. Lancet HIV
- Early antiretroviral therapy in HIV-infected infants: can it lead to HIV remission?
- (2018) Stephanie Shiau et al. Lancet HIV
- Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension
- (2018) Maelíosa T.C. Mc Crudden et al. JOURNAL OF CONTROLLED RELEASE
- Assessing the adoption of lopinavir/ritonavir oral pellets for HIV ‐positive children in Zimbabwe
- (2018) Briony Pasipanodya et al. Journal of the International AIDS Society
- Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges
- (2016) Rashida A. Ferrand et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Very early combination antiretroviral therapy in infants
- (2015) Kaitlin Rainwater-Lovett et al. Current Opinion in HIV and AIDS
- Optimizing drugs to reach treatment targets for children and adolescents living with HIV
- (2015) Martina Penazzato et al. Journal of the International AIDS Society
- Adherence to antiretroviral therapy in adolescents living with HIV
- (2014) Sung-Hee Kim et al. AIDS
- The Adolescent and Young Adult HIV Cascade of Care in the United States: Exaggerated Health Disparities
- (2014) Brian C. Zanoni et al. AIDS PATIENT CARE AND STDS
- Ethical Issues in Adolescent HIV Research in Resource-Limited Countries
- (2013) Linda-Gail Bekker et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Adolescent Dosing and Labeling Since the Food and Drug Administration Amendments Act of 2007
- (2013) Jeremiah D. Momper et al. JAMA Pediatrics
- Population Pharmacokinetics of Palivizumab, a Humanized Anti-Respiratory Syncytial Virus Monoclonal Antibody, in Adults and Children
- (2012) Gabriel J. Robbie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adherence and Viral Suppression Among Infants and Young Children Initiating Protease Inhibitor-based Antiretroviral Therapy
- (2012) Chloe A. Teasdale et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now